The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
From new findings in acne pathogenesis to new approaches in treatment
Open accessAbstract
Acne is a chronic disease of the pilosebaceous unit which is most common during adolescence. Four factors are believed to play a key role in the development of acne lesions: excess sebum production, disturbed keratinization within the follicle, colonization of the pilosebaceous duct by Propionibacterium acnes, and the release of inflammatory mediators into the skin. Consequently, in order to effectively and rapidly reduce acne lesions, treatments need to address as many of these underlying factors as possible. Currently, about half of patients have poor adherence to acne treatments. To overcome this limitation, treatments need to be developed which are well tolerated by patients, and easy for them to use, handle and apply. Topical monotherapies for acne such as retinoids and antimicrobials by themselves have a restricted range of actions against the pathogenic factors of acne. Instead, the Global Alliance to Improve Outcomes in Acne Group recommends combination therapy with a topical retinoid and an antimicrobial agent as the preferred approach for almost all acne patients. The principal advantage of such combinations is that they target more of the underlying pathogenic factors of acne than individual monotherapies and this results in faster and more complete clearing of acne lesions. Fixed‐dose combinations are also more convenient than applying two medications separately, which leads to improved adherence with the regimen. By normalizing desquamation, the retinoid component of these combinations allows entry of the antimicrobial agent into the pilosebaceous unit resulting in faster clearance of P. acnes. In conclusion, topical retinoid/antimicrobial fixed‐dose combinations represent a rational approach for the treatment of acne. They should be considered as the cornerstone of acne management and should be used much more in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Hormones in Pilosebaceous Unit Development
Deplewski, D., & Rosenfield, R. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.4.0404 · Cited by 443
Jr, O. M., Thornsberry, C., Cardin, C. W., Smiles, K. A., & Leyden, J. J. (2002) · Acta Dermato-Venereologica · doi:10.1080/000155502320323216 · Cited by 115
Cited by
Balić, A., Vlašić, D., Žužul, K., Marinović, B., & Bukvić Mokos, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030741 · Cited by 400
The epidemiology of acne vulgaris in late adolescence
Lynn, D., Umari, T., Dellavalle, R., & Dunnick, C. (2016) · Adolescent Health, Medicine and Therapeutics · doi:10.2147/ahmt.s55832 · Cited by 332
Air pollution and skin disorders
Roberts, W. (2021) · International Journal of Women's Dermatology · doi:10.1016/j.ijwd.2020.11.001 · Cited by 111
Interventions to increase adherence to acne treatment
Moradi Tuchayi, S., Alexander, T., Nadkarni, A., & Feldman, S. R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s117437 · Cited by 78
“15 However, combination treatments have overcome all adherence obstacles, especially in maintaining good adherence over time.”
Dermocosmetics: beneficial adjuncts in the treatment of acne vulgaris
Araviiskaia, E., Lopez Estebaranz, J. L., & Pincelli, C. (2021) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1628173 · Cited by 47
Kulthanan, K., Trakanwittayarak, S., Tuchinda, P., Chularojanamontri, L., Limphoka, P., & Varothai, S. (2020) · BioMed Research International · doi:10.1155/2020/2857812 · Cited by 24
Dall'Oglio, F., Fabbrocini, G., Tedeschi, A., Donnarumma, M., Chiodini, P., & Micali, G. (2020) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s206935 · Cited by 15
Metadata
- Authors
- Gollnick, H. P. M.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2015-06
- Volume
- 29
- Issue
- S5
- Pages
- 1-7
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W1659673907
- Cited by
- 174
- References
- 2
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.